TVRD
Tvardi Therapeutics, Inc. Common Stock ·
Tvardi Therapeutics, Inc. Common Stock (TVRD) is held by 1 tracked hedge fund(s). Largest tracked holder: Slate Path Capital LP.
No recent hedge-fund trades on this stock.
Recent hedge fund trades
No recent hedge-fund trades on this stock.
Insider trades open-market, past year
No reported open-market insider trades in the past year.
Open-market Form 4 transactions (grants & option exercises excluded). Live from SEC filings.
Congress buys & sells disclosed trades
No disclosed Congressional trades on this stock.
Price chart
Financials
Symbol info, price chart & financials are live from TradingView (real data — no processing).
📊
Deep Dive — full fundamental analysis
An analyst-grade breakdown of TVRD: the bull & bear thesis, valuation model, segment detail and risks — written from SEC filings.
- Bull & bear case, with conviction score
- Owner-earnings & valuation model
- Segment & geographic revenue breakdown
- Key risks & what would break the thesis
- Peer comparison (vs sector)
🔒 Unlock with WealthFile Pro
⚡
Daily Moves — what's moving TVRD today
A daily, plain-English read on the day's price action and the smart-money & news catalysts behind it.
- Today's price drivers, explained
- Smart-money flow alerts (fund / insider / Congress)
- News & SEC-filing catalysts
- Unusual options activity
🔒 Unlock with WealthFile Pro
Related ▾
FAQ ▾
Which hedge funds hold TVRD?
Tracked holders include: Slate Path Capital LP.
How much smart money owns TVRD?
1 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading TVRD?
No tracked Congressional trades in TVRD on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.